Beta-blockers versus diuretics in hypertensive men: Main results from the happhy trial

Journal of Hypertension

Volumn 5, Issue 5, 1987, Pages 561-572

  Wilhelmsen, Lars ^a   Berglund, Göran ^a   Elmfeldt, Dag ^a   Fitzsimons, Timothy ^b   Holzgreve, Heinz ^c   Hosie, James ^d   Hörnkvist, Per Erik ^e   Pennert, Kjell ^a   Tuomilehto, Jaakko ^f   Wedel, Hans ^g  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Wilton Centre   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ICI Pharma ^*  (United Kingdom)

^e National Public Health Institute ^*  (Sweden)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC BETA ANTAGONISTS; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; MALE; MORTALITY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; CLINICAL PROTOCOLS; CLINICAL TRIALS; COMPARATIVE STUDY; DIURETICS, THIAZIDE; FOLLOW-UP STUDIES; HEART RATE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023433489     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-198710000-00009     Document Type: Article

References (31)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129mmHg. JAMA 1967, 202:1028–1034.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. JAMA 1970, 213:1143–1152.
3. Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of the hypertension detection of follow-up program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979, 242:2562–2571.
4. Australian National Blood Pressure Study Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980, i:1261–1267.
5. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982, 248:1465–1477.
6. Wilhelmsson C, Vedin JA, Wilhelmsen L, Tibblin G: Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 1974, ii: 1157–1159.
7. Ahlmark G, Saetre H, Korsgren M: Reduction of sudden deaths after myocardial infarction. Lancet 1974, ii: 1563.
8. A Multicentre International Study: Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade using practolol. Br Med J 1975, 3:735–740.
9. Hjalmarson Å, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Rydén L, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C: Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981, ii:823–827.
10. Norwegian Multicentre Study Group: Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981, 304:801–807.
11. Beta-blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. Mortality results. JAMA 1982, 247:1707–1714.
12. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27:335–371.
13. Medical Research Council Working Party: MRC Trial of Treatment of Mild Hypertension: principal results. Br Med J 1985, 291:97–104.
14. IPPPSH Collaborative Group: Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertension 1985, 3:379–392.
15. Amery A, Birkenhäger W, Brixko P, Bulpitt C, De Schaepdryver A, Fagard R, Forte J, Henry JF, Leonetti G, O’Malley K, Strasser T, Deruyttere M, Dollery C, Forette F, Hamdy R, Joossens JV, Lund-Johansen P, Petrie J, Tuomilehto J: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985, i:1349–1354.
16. Coope J, Warrender TS: Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986, 293:1146–1151.
17. Wilhelmsen L, Wedel H, Tibblin G: Multivariate analysis of risk factors for coronary heart disease. Circulation 1973, 48:950–958.
18. Wilhelmsen L, Berglund G, Elmfeldt D, Wedel H: Beta-blockers versus saluretics in hypertension. Prev Med 1981, 10:38–49.
19. Kaplan EL, Meier P: Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958, 53:457–481.
20. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc, Series B 1972, 34:182–202.
21. Fager G, Berglund G, Bondjers G, Elmfeldt D, Lager I, Olofsson S-O, Smith U, Wiklund O: Effects of antihypertensive therapy on serum lipoproteins. Artery 1983, 11:283–296.
22. Weidmann P, Uehlinger DE, Gerber A: Antihypertensive treatment and serum lipoproteins. J Hypertension 1985, 3:297–306.
23. Pedersen TR: A multicenter study on timolol in secondary prevention after myocardial infarction. PhD thesis, University of Bergen, Norway, 1983, pp 79–85.
24. Olsson G, Rehnqvist N: Reduction of nonfatal reinfarctions in patients with a history of hypertension by chronic postinfarction treatment with metoprolol. Acta Med Scand 1986, 220:33–38.
25. Olsson G, Rehnqvist N, Sjögren A, Erhardt L, Lundman T: Long-term treatment with metoprolol after myocadial infarction: effect on three year mortality and morbidity. J Am Coll Cardiol 1985, 5:1428–1437.
26. Greenburg G, Thompson SG: The effect of smoking on blood pressure in mild hypertensives, and on their response to antihypertensive treatment. J Hypertension 1984, 2:553.
27. Fager B, Liedholm H, Monti M: Thermogenesis in human skeletal muscle as measured by direct microcalorimetry and muscle contractile performance during beta-adrenoceptor blockade. Clin Sci 1986, 70:435–441.
28. Rasmussen S, Rasmussen K: Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension. Eur J Clin Pharmacol 1979, 15:305–310.
29. Berglund G, Andersson O, Widgren B: A low-dose antihypertensive treatment with a thiazide diuretic is not diabeto genic: A 10-year controlled trial with bendroflumethiazide. J Hypertension 1986; 4 (suppl 5):S525–S527.
30. Amery A, Berthaux P, Bulpitt C, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Hellemans J, Lund-Johansen P, Mutsers A, Tuomilehto J: Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on High Blood Pressure in the Elderly. Lancet 1978, i:681–683.
31. Berglund G, Larsson B, Andersson O, Larsson O, Svärdsudd K, Björntorp P, Wilhelmsen L: Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 1976, 200:163–169.